Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Claritas Pharmaceuticals Inc V.CLAS.H

Alternate Symbol(s):  CLAZF

Claritas Pharmaceuticals, Inc., formerly Kalytera Therapeutics Inc, is a biotechnology company that is focused on developing R-107 for the treatment of vaccine-resistant coronavirus disease (COVID) strains. The Company’s products in development include R-107 for coronavirus disease and Viral Infections, R-107 and Vaccines, and CLA-1816 for treatment of pain. R-107 is designed to defeat COVID... see more

TSXV:CLAS.H - Post Discussion

Claritas Pharmaceuticals Inc > Bob Farrell Email
View:
Post by PTBailey on Apr 27, 2021 7:37pm

Bob Farrell Email

Reverse Split, Institutional Investors and Positive Developments.
https://claritasinvestors.com/index.php?/topic/833-email-bob-farrell-april-27-2021/&tab=comments#comment-2728
Comment by whisky11 on Apr 27, 2021 8:00pm
Win win situation. With $0.50 stock price we will get institutional investors on the board and shares offering at better price. Bad feelings after  consolidation will be offset by bunch of positive press releases. After all, consolidation leave us with the same money, the problem is with shorters. But then strong positive information will take care about them.
Comment by 011Peking on Apr 27, 2021 9:01pm
One thing i don't get is why would institutional investors jump on the train at $0.5 and not on $0.05? there's no difference other then less shares out there? 50m instead of 500mil with an RS of 10/1?
Comment by whisky11 on Apr 27, 2021 9:13pm
011Peking] One thing i don't get is why would institutional investors jump on the train at $0.5 and not on $0.05? there's no difference other then less shares out there? 50m instead of 500mil with an RS of 10/1? whisky11: at five cents a share Company cannot raise funds. Institutional investors buy stocks for clients. Haruki Murakami > Quotes > Quotable Quote  ...more  
Comment by PTBailey on Apr 28, 2021 9:48am
My understanding is they won't invest in penny stocks.
Comment by ETalien on Apr 27, 2021 9:29pm
Excellent! Thanks for posting...
Comment by polygraph46 on Apr 28, 2021 1:03am
Re: Farrell Email.  Bailey, what I would like to know, is this an official communication from the President of the Company (Farrell) to you and others in the Conclave touting the benefits of massive share consolidation?  Like, if that is so, then why has it not been released as NEWS by the Company?  And then you, in mouthpuppet fashion come out from behind the curtain with ...more  
Comment by PTBailey on Apr 28, 2021 9:53am
I would be much more willing to answer you question minus the insinuations, accuasations and general A**hole attitude. It is word for word response to a question to Bob Farrell and if it we for a select group it wouldn't have been shared. Don't believe it contact him and confirm. Next time be a little more respectful.
Comment by PTBailey on Apr 28, 2021 11:55am
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities